Benralizumab Biosimilar (IL-5Ra/ CD125 Reference Antibody)
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα) -directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma.
Product Specifications
Target
Benralizumab Biosimilar (Anti-IL-5Ra/ CD125 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
033913-FITC 200 µL
CIDEC, ID (CIDEC, FSP27, Cell death activator CIDE-3, Cell death-inducing DFFA-like effector protein C, Fat-specific protein FSP27 homolog) (FITC) discontinued
Sign In for Pricing
View Details MBS1246839-01 0.02 mg (E-Coli)
Recombinant Bacillus anthracis Bifunctional protein pyrR (pyrR)
Sign In for Pricing
View Details MBS1246839-02 0.1 mg (E-Coli)
Recombinant Bacillus anthracis Bifunctional protein pyrR (pyrR)
Sign In for Pricing
View Details MBS1246839-03 0.02 mg (Yeast)
Recombinant Bacillus anthracis Bifunctional protein pyrR (pyrR)
Sign In for Pricing
View Details